TransEasy opens East China production and operations base in WND

The East China production and operation base of TransEasy in WND. [Photo/WeChat account: xinwu_wx]

TransEasy, a national high-tech enterprise specializing in general surgery medical devices, inaugurated its East China Production and Operations Base in the Wuxi National Hi-Tech District (WND) on Feb 5, marking a major milestone in the company's expansion.

Headquartered in Beijing, TransEasy has established a leading position in hernia and abdominal wall surgery.

The East China production and operation base of TransEasy in WND. [Photo/WeChat account: xinwu_wx]

With a total investment of 520 million yuan ($74.92 million), the newly launched East China base integrates research, testing, manufacturing, operations, marketing, and training. Once fully operational, the facility is expected to reach an annual production capacity of 330,000 sets of medical products.

Liu Jian, chairman of TransEasy, said the company will use the new facility as a starting point to further increase investment in research and development, accelerate product innovation and upgrades, better serve clinical needs, and strive to become a benchmark enterprise in the regional medical device industry.

In recent years, WND has concentrated on expanding into global frontiers in life and health sciences, accelerating the development of a biomedical ecosystem that boasts strong international competitiveness. By 2025, the district's biomedical industry exceeded 100 billion yuan in scale, accounting for nearly half of Wuxi's total and ranking among the top biomedical parks nationwide.

The East China production and operation base of TransEasy in WND. [Photo/WeChat account: xinwu_wx]

WND is now home to more than 850 biomedical companies, including those focused on innovative drugs, medical devices, pharmaceutical research and development services, metabolic medicines, and health-related consumer products. The district is also actively identifying future growth areas, including nuclear medicine, brain-computer interfaces, and cell and gene therapy.